Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.24.1.u1
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Revenues $ 29,722,166 $ 28,300,820
Depreciation and amortization 1,403,906 2,215,055
Segment operating (loss) income 1,090,276 (653,109)
Other income, net 35,630 3,821,162
Income before income tax expense 1,125,906 3,168,053
Operating Segments    
Segment Reporting Information [Line Items]    
Segment operating (loss) income 6,824,858 4,119,846
Unallocated corporate    
Segment Reporting Information [Line Items]    
Segment operating (loss) income (5,734,582) (4,772,955)
Corporate clinics    
Segment Reporting Information [Line Items]    
Revenues 17,537,504 17,127,957
Corporate clinics | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 1,104,232 1,927,091
Segment operating (loss) income 1,486,910 (422,053)
Franchise operations    
Segment Reporting Information [Line Items]    
Revenues 12,184,662 11,172,863
Franchise operations | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 219,250 198,974
Segment operating (loss) income 5,337,948 4,541,899
Corporate administration    
Segment Reporting Information [Line Items]    
Depreciation and amortization $ 80,424 $ 88,990